CLASS II Device recall · Reported 12 Feb 2020 · FDA Enforcement Report

Accu-Chek Aviva Plus Retail Strips - intended recalled

Roche Diabetes Care is recalling Accu-Chek Aviva Plus Retail Strips - intended for Blood Glucose Monitoring System, distributed nationwide in the US. The recall was initiated on 11 Dec 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7
Quantity recalled92,836 vials

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0998-2020
FDA event ID
84518
Recalling firm
Roche Diabetes Care, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
11 Dec 2019
FDA classified
5 Feb 2020
Reported
12 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

11 Dec 2019Recall initiated by company
5 Feb 2020Classified by FDA+56 days
12 Feb 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

Accu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System Catalog Number: 06908217001

Where it was distributed

Nationwide: Foreign: Austalia, India

Nationwide

Questions about this recall

Is Accu-Chek Aviva Plus Retail Strips - intended for Blood Glucose Monitoring System recalled?

Yes. Roche Diabetes Care recalled Accu-Chek Aviva Plus Retail Strips - intended for Blood Glucose Monitoring System on 11 Dec 2019. The recall is Class II and its status is Terminated. Recall number Z-0998-2020.

Why was it recalled?

Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions

Which lots are affected?

Lot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7

Where was it sold?

Nationwide: Foreign: Austalia, India

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diabetes Care

All 29

Other Insulin Pumps & Glucose Monitors recalls

All 459